Expired Canadian patentCanada
Liposomal vaccines comprising dilipopeptides for modulating t1 and t2 immune responses
CA 2441809 C · Owner: Biomira, Inc. · Inventors: Longenecker, Michael B.; Koganty, Rao R.; Krantz, Mark J.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides liposomal vaccines containing immunogenic dilipopeptides that , are capable of modulating the humoral and cellular immune responses in vivo.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2002 and granted July 22, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 27, 2002
GrantedJuly 22, 2014
Term endedMarch 27, 2022
Patent numberCA 2441809 C
Classification (IPC)C07K14/47 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.